Stem-Cell Wonderland
By Ralph Brave,
Sacramento News & Review
| 10. 20. 2005
Will cures be affordable to all?
Last week, a middle-aged woman from Maryland sat in the Denver airport, reading a story in The New York Times headlined "California Maps Strategy for Its $3 Billion Stem Cell Project." Asked whether she's professionally involved in the life sciences, she said, "No." Why then was she reading this particular article? Without hesitation she replied, "My father died from Parkinson's disease."
So it is around the state, the nation and even the globe: Having launched a major stem-cell venture nearly a year ago, California is being watched and looked to for stem-cell cures for all kinds of chronic diseases and conditions.
But the woman in the airport would not have been encouraged by the tale told in the most recent University of California, Berkeley, alumni magazine of a woman near her own age suffering from Parkinson's. This woman's husband happens to be both a cell biologist and director of Berkeley's stem-cell center. When it comes to the prospect of a stem-cell therapy to save his wife or any other Parkinson's patient, he states his scientific opinion succinctly: "Right now, it's...
Related Articles
By Natalie Ram, Anya E. R. Prince, Jessica L. Roberts, Dov Fox, and Kayte Spector-Bagdady, Science | 09.11.2025
After declaring bankruptcy in March 2025, direct-to-consumer (DTC) genetic testing company 23andMe sold the data of more than 15 million people around the world to TTAM Research Institute, a nonprofit organization created by 23andMe’s founder and long-time CEO. 23andMe’s customers...
By Gina Kolata, The New York Times | 09.22.2025
On May 26, Tracy Atteberry checked in to the hospital at the National Institutes of Health in Bethesda, Md. The 57-year-old has an ultrarare inherited disease that hobbles his immune system so that the most innocuous of germs could kill...
By Dennis Sponer, BioSpace | 09.03.2025
Imagine telling a child with sickle cell disease that a cure exists—but it’s too expensive for their insurer to cover. That’s not a hypothetical. It’s the reality of gene therapy today: a revolutionary medical breakthrough caught in the bottleneck of...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...